ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE European Orphan Drug Designation for VP
|
|
RTheo
|
16 |
3.7K |
3 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
16
|
3.7K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE European Orphan Drug Designation for VP
|
|
RTheo
|
16 |
3.7K |
0 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
16
|
3.7K
|
0
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Anything but Charting
|
|
RTheo
|
30K |
13M |
2 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
30K
|
13M
|
2
|
|
ASX - By Stock
|
CUV |
Re:
Taco shop worth more than Clinuvel
|
|
RTheo
|
7 |
2.3K |
1 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
7
|
2.3K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
RTheo
|
4.2K |
3.8M |
11 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
RTheo
|
4.2K |
3.8M |
5 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
5
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
RTheo
|
11K |
6.1M |
7 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
11K
|
6.1M
|
7
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
RTheo
|
117 |
49K |
4 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
117
|
49K
|
4
|
|
ASX - By Stock
|
4DS |
Re:
Stock Soiree event at Perth Wed 17th April 2024
|
|
RTheo
|
23 |
8.0K |
1 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
23
|
8.0K
|
1
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Peter Himes Appointed to Chief Strategic Officer
|
|
RTheo
|
52 |
20K |
10 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
52
|
20K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
RTheo
|
608 |
211K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
608
|
211K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
RTheo
|
608 |
211K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
608
|
211K
|
4
|
|
ASX - By Stock
|
4DS |
Re:
4DS - Memory Chip The Best Update Sofar - posted on 7 April 2024
|
|
RTheo
|
88 |
35K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
88
|
35K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
RTheo
|
608 |
211K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
608
|
211K
|
2
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
RTheo
|
75 |
39K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
75
|
39K
|
0
|
|
ASX - By Stock
|
KSL |
Re:
Ann: Suspension from Quotation
|
|
RTheo
|
21 |
5.9K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
21
|
5.9K
|
0
|
|
ASX - By Stock
|
KSL |
Re:
Ann: Suspension from Quotation
|
|
RTheo
|
21 |
5.9K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
21
|
5.9K
|
1
|
|
ASX - By Stock
|
KSL |
Re:
Ann: Suspension from Quotation
|
|
RTheo
|
21 |
5.9K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
21
|
5.9K
|
0
|
|
ASX - By Stock
|
KSL |
Re:
Ann: Suspension from Quotation
|
|
RTheo
|
21 |
5.9K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
21
|
5.9K
|
0
|
|
ASX - By Stock
|
KSL |
Re:
Ann: Suspension from Quotation
|
|
RTheo
|
21 |
5.9K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
21
|
5.9K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
RTheo
|
670 |
256K |
8 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
670
|
256K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
RTheo
|
54 |
17K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
54
|
17K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Disc Medicine - Best comparison stock to Clinuvel
|
|
RTheo
|
106 |
44K |
5 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
106
|
44K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
RTheo
|
54 |
17K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
54
|
17K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
RTheo
|
54 |
17K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
54
|
17K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Disc Medicine - Best comparison stock to Clinuvel
|
|
RTheo
|
106 |
44K |
6 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
106
|
44K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
RTheo
|
4.2K |
3.8M |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Disc Medicine - Best comparison stock to Clinuvel
|
|
RTheo
|
106 |
44K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
106
|
44K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
What is going on...
|
|
RTheo
|
32 |
13K |
0 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
32
|
13K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
What is going on...
|
|
RTheo
|
32 |
13K |
8 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
32
|
13K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CUV Appendix 4D Half Year Report
|
|
RTheo
|
26 |
9.3K |
8 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
26
|
9.3K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
RTheo
|
327 |
106K |
15 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
327
|
106K
|
15
|
|
ASX - By Stock
|
ALU |
Re:
Ann: Altium enters into binding SIA with Renesas
|
|
RTheo
|
59 |
40K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
59
|
40K
|
1
|
|
ASX - By Stock
|
FID |
Re:
Ann: Fiducian (FID) Investor Presentation H1 2023-24 Results
|
|
RTheo
|
27 |
11K |
7 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
27
|
11K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
RTheo
|
974 |
323K |
3 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
974
|
323K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
RTheo
|
974 |
323K |
20 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
974
|
323K
|
20
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Results of Annual General Meeting
|
|
RTheo
|
396 |
116K |
7 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
396
|
116K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
RTheo
|
95 |
28K |
13 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
95
|
28K
|
13
|
|
ASX - By Stock
|
4DS |
Re:
2023 CHART THREAD
|
|
RTheo
|
1.3K |
496K |
9 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
1.3K
|
496K
|
9
|
|
ASX - By Stock
|
GMG |
Re:
Ann: Q1 FY24 Operational Update
|
|
RTheo
|
15 |
4.4K |
1 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
15
|
4.4K
|
1
|
|
ASX - By Stock
|
GMG |
Re:
Ann: Q1 FY24 Operational Update
|
|
RTheo
|
15 |
4.4K |
0 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
15
|
4.4K
|
0
|
|
ASX - By Stock
|
GMG |
Re:
Ann: Q1 FY24 Operational Update
|
|
RTheo
|
15 |
4.4K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
15
|
4.4K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
RTheo
|
4.2K |
3.8M |
1 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
|
|
RTheo
|
237 |
74K |
15 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
237
|
74K
|
15
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Becoming a substantial holder
|
|
RTheo
|
315 |
127K |
0 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
315
|
127K
|
0
|
|
ASX - By Stock
|
CIP |
Re:
Ann: 2023 Annual Report
|
|
RTheo
|
3 |
1.3K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
RTheo
|
974 |
323K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
974
|
323K
|
1
|
|
ASX - By Stock
|
RUL |
Re:
Ann: Q1-FY24 Business Update
|
|
RTheo
|
6 |
3.5K |
4 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
6
|
3.5K
|
4
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Trading Halt
|
|
RTheo
|
463 |
179K |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
463
|
179K
|
2
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Megabit Success
|
|
RTheo
|
2.6K |
867K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
2.6K
|
867K
|
1
|
|